2009
DOI: 10.1073/pnas.0811514106
|View full text |Cite
|
Sign up to set email alerts
|

Drug efflux pump deficiency and drug target resistance masking in growing bacteria

Abstract: Recent experiments have shown that drug efflux pump deficiency not only increases the susceptibility of pathogens to antibiotics, but also seems to ''mask'' the effects of mutations, that decrease the affinities of drugs to their intracellular targets, on the growth rates of drug-exposed bacteria. That is, in the presence of drugs, the growth rates of drug-exposed WT and target mutated strains are the same in a drug efflux pump deficient background, but the mutants grow faster than WT in a drug efflux pump pro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
36
0
1

Year Published

2011
2011
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(39 citation statements)
references
References 23 publications
2
36
0
1
Order By: Relevance
“…The dissociation of macrolidebound ribosome promoted by ORF-16 TYL 10 is believed to reset the stalled ribosome to allow productive translation. Concerning the apparent AcrAB dependency of the ORF-16 TYL 10 -conferred resistance, observations highly similar to ours, in which the macrolide resistance caused by ribosomal mutation was "masked" by drug efflux pump deficiency, have been reported for several bacteria, including E. coli (39). This so-called "drug target mutation masking" effect in response to efflux pump inhibition is fundamentally linked to growth bistability and is favored by factors including high-affinity drug binding to its target and high target abundance within bacterial cells (39), both of which are applicable in the case of macrolide antibiotics and their ribosomal target.…”
Section: Figsupporting
confidence: 72%
“…The dissociation of macrolidebound ribosome promoted by ORF-16 TYL 10 is believed to reset the stalled ribosome to allow productive translation. Concerning the apparent AcrAB dependency of the ORF-16 TYL 10 -conferred resistance, observations highly similar to ours, in which the macrolide resistance caused by ribosomal mutation was "masked" by drug efflux pump deficiency, have been reported for several bacteria, including E. coli (39). This so-called "drug target mutation masking" effect in response to efflux pump inhibition is fundamentally linked to growth bistability and is favored by factors including high-affinity drug binding to its target and high target abundance within bacterial cells (39), both of which are applicable in the case of macrolide antibiotics and their ribosomal target.…”
Section: Figsupporting
confidence: 72%
“…In addition, the rate of lac gene expression itself can depend on growth [13], [14]. Similar growth feedback mechanisms have been argued to play an important role in bacterial drug resistance [15], [16], and to generate diversity in an isogenic population [13], [15], [17].…”
Section: Introductionmentioning
confidence: 82%
“…In addition, increased expression of efflux pumps may permit bacteria to survive otherwise lethal concentrations of substrate antibiotics and thus allow selection for target mutations that increase drug resistance levels. This phenomenon is known as "drug target resistance masking" (14). Together, this underlines the role of efflux pumps in the development of high levels of multidrug resistance.…”
Section: Resultsmentioning
confidence: 99%